Left Ventricular Assist Device as Destination Therapy
... prognostic data is available from INTERMACS, the unique registry of LVAD recipients in the USA which is sponsored by the National Heart, Lung, and Blood Institute, the Centers for Medicare and Medicaid Services, FDA, and industry. Patients who are entered into the registry are categorized into one o ...
... prognostic data is available from INTERMACS, the unique registry of LVAD recipients in the USA which is sponsored by the National Heart, Lung, and Blood Institute, the Centers for Medicare and Medicaid Services, FDA, and industry. Patients who are entered into the registry are categorized into one o ...
Grading diastolic function by echocardiography: hemodynamic
... SBP systolic blood pressure, DBP diastolic blood pressure, LVEDP left ventricular end-diastolic pressure, CAD coronary artery disease ...
... SBP systolic blood pressure, DBP diastolic blood pressure, LVEDP left ventricular end-diastolic pressure, CAD coronary artery disease ...
Cardiovascular Risk Reduction in Patients with Type 2 Diabetes
... For those who are later in their diabetes course, metaanalyses of glycemic control trials, along with follow-up studies, have also shown that better glycemic control can reduce cardiovascular events, but not mortality [15–17]. Therefore, glucose lowering should be pursued for cardiovascular risk red ...
... For those who are later in their diabetes course, metaanalyses of glycemic control trials, along with follow-up studies, have also shown that better glycemic control can reduce cardiovascular events, but not mortality [15–17]. Therefore, glucose lowering should be pursued for cardiovascular risk red ...
Print this article - Medical Journal of Indonesia
... without increasing bleeding risk any further. Increasing evidence showed a promising efficacy and safety of oral fibrin specific lumbrokinase as a thrombolytic agent. To the best of our knowledge, report of the use of lumbrokinase on intracardiac thrombus is limited. We reported two cases of intraca ...
... without increasing bleeding risk any further. Increasing evidence showed a promising efficacy and safety of oral fibrin specific lumbrokinase as a thrombolytic agent. To the best of our knowledge, report of the use of lumbrokinase on intracardiac thrombus is limited. We reported two cases of intraca ...
Invasive and non-invasive methods for cardiac output measurement
... contour, partial CO2 rebreathing and thoracic electrical bioimpedance. All of them have their advantages and disadvantages, but thermodilution is the golden standard for critical patients, although it does entail many risks. The ideal system for cardiac output monitoring would be non-invasive, easy ...
... contour, partial CO2 rebreathing and thoracic electrical bioimpedance. All of them have their advantages and disadvantages, but thermodilution is the golden standard for critical patients, although it does entail many risks. The ideal system for cardiac output monitoring would be non-invasive, easy ...
- Wiley Online Library
... acquired during repeated breath-holds in standard long axes (four-, three-, and two-chamber views) and in a stack of short axes covering the whole left ventricle (LV) from base to apex (no interslice gap). Imaging parameters were: repetition time (TR) 3.1 msec, echo time (TE) ...
... acquired during repeated breath-holds in standard long axes (four-, three-, and two-chamber views) and in a stack of short axes covering the whole left ventricle (LV) from base to apex (no interslice gap). Imaging parameters were: repetition time (TR) 3.1 msec, echo time (TE) ...
Asymptomatic Patient Screening
... A screening test must be accurate, reproducible, and provide information that can lead to a recommended course of action, suggest therapy or provide a prognosis. Non-invasive tests like echocardiography and the 12-lead ECG lack sufficient sensitivity to be useful screening tools for cardiovascular d ...
... A screening test must be accurate, reproducible, and provide information that can lead to a recommended course of action, suggest therapy or provide a prognosis. Non-invasive tests like echocardiography and the 12-lead ECG lack sufficient sensitivity to be useful screening tools for cardiovascular d ...
Outcomes of Patients With Prior Coronary Artery Bypass Grafting
... prior CABG are shown in Figure 4. MACE at 30 days and 1 year were not significantly different after randomization to bivalirudin compared with heparin plus a GPI. Discussion The main results of the present analysis are as follows. 1) Prior CABG is common in patients admitted for ACS. 2) Patients wit ...
... prior CABG are shown in Figure 4. MACE at 30 days and 1 year were not significantly different after randomization to bivalirudin compared with heparin plus a GPI. Discussion The main results of the present analysis are as follows. 1) Prior CABG is common in patients admitted for ACS. 2) Patients wit ...
Pattern of coronary artery dominancy by coronary angiography
... stated that both the coronary diseases and coronary artery variations are more common in individuals with left dominance circulation.4 The distribution of atherosclerotic lesions has been shown both in animals and in man to be patchy but non-random.13 However, in Balci et al. study reported that the ...
... stated that both the coronary diseases and coronary artery variations are more common in individuals with left dominance circulation.4 The distribution of atherosclerotic lesions has been shown both in animals and in man to be patchy but non-random.13 However, in Balci et al. study reported that the ...
What Is A Patent Foramen Ovale?
... population, however, the atrial septum does not close properly. In this case it is called a patent foramen ovale, or PFO. ...
... population, however, the atrial septum does not close properly. In this case it is called a patent foramen ovale, or PFO. ...
Inflammatory Response and Congestive Heart Failure Following
... related to a combination of volume overload, increased circulating cytokine levels, or reduction in natriuretic peptides with extensive ablation of atrial tissue.4 The appearance of symptoms 3-4 days post-ablation procedure makes direct volume overload an unlikely cause of this syndrome. Tan et al h ...
... related to a combination of volume overload, increased circulating cytokine levels, or reduction in natriuretic peptides with extensive ablation of atrial tissue.4 The appearance of symptoms 3-4 days post-ablation procedure makes direct volume overload an unlikely cause of this syndrome. Tan et al h ...
Chronic heart failure in adults: management
... This guideline offers best practice advice on the care of adults with chronic heart failure. Treatment and care should take into account patients' needs and preferences. People with chronic heart failure should have the opportunity to make informed decisions about their care and treatment, in partne ...
... This guideline offers best practice advice on the care of adults with chronic heart failure. Treatment and care should take into account patients' needs and preferences. People with chronic heart failure should have the opportunity to make informed decisions about their care and treatment, in partne ...
Mechanism and significance of a decrease in ejection fraction
... hypokmetic, 3 = less than Y2 wall akmetic, 4 = greater than Y2 wall akinetic, 5 = less than Y2 wall dyskmetic and 6 = greater than Y2 wall dyskmetic To distmguish between global and regional left ventncular dysfunction, asynergy of wall motion was defined as a difference of at least two grades betwe ...
... hypokmetic, 3 = less than Y2 wall akmetic, 4 = greater than Y2 wall akinetic, 5 = less than Y2 wall dyskmetic and 6 = greater than Y2 wall dyskmetic To distmguish between global and regional left ventncular dysfunction, asynergy of wall motion was defined as a difference of at least two grades betwe ...
ACEIs/ARBs for the prevention of type 2 diabetes in patients with
... angiotensin receptor blockers (ARBs) reduce the incidence of type 2 diabetes in patients with cardiovascular diseases. Therefore, a systematic review and meta-analysis was performed to assess the clinical efficacy of ACEIs and ARBs in preventing type 2 diabetes. Methods: Randomized controlled trials ...
... angiotensin receptor blockers (ARBs) reduce the incidence of type 2 diabetes in patients with cardiovascular diseases. Therefore, a systematic review and meta-analysis was performed to assess the clinical efficacy of ACEIs and ARBs in preventing type 2 diabetes. Methods: Randomized controlled trials ...
Amiodarone for resuscitation after out-of
... assumed to be present if there was a need for the infusion of vasopressor agents or for chronotropic therapy after spontaneous circulation had been restored. Survival to discharge from the hospital and functional neurologic status at discharge were also evaluated, although the trial, by design, did ...
... assumed to be present if there was a need for the infusion of vasopressor agents or for chronotropic therapy after spontaneous circulation had been restored. Survival to discharge from the hospital and functional neurologic status at discharge were also evaluated, although the trial, by design, did ...
comparison of efficacy of intravenous adenosine and verapamil in
... maneuvers. Group A patients received adenosine 6 milligrams (mg) IV bolus. It was followed by 12mg IV bolus, if PSVT not reverted. Group B patients received verapamil 5mg IV, three consecutive doses at 5 minutes interval till PSVT was reverted into sinus rhythm. Time from the administration of drug ...
... maneuvers. Group A patients received adenosine 6 milligrams (mg) IV bolus. It was followed by 12mg IV bolus, if PSVT not reverted. Group B patients received verapamil 5mg IV, three consecutive doses at 5 minutes interval till PSVT was reverted into sinus rhythm. Time from the administration of drug ...
effects of a randomized controlled trial of diet and/or exercise on
... addition to advances in medical care and management of cardiovascular and other diseases 3,4. By 2040, it is projected there will be 77.2 million new HF cases 6. Even more alarming, an underestimation of rates most likely occurs because some patients who have left ventricular dysfunction are asympto ...
... addition to advances in medical care and management of cardiovascular and other diseases 3,4. By 2040, it is projected there will be 77.2 million new HF cases 6. Even more alarming, an underestimation of rates most likely occurs because some patients who have left ventricular dysfunction are asympto ...
Managing low cardiac output syndrome after congenital heart surgery
... defies placing narrow limits on recommended dosages. Dobutamine’s chronotropic and vasodilatory advantages recognized in adults with coronary artery disease have not always proved equally efficacious in clinical studies in children. In fact, dobutamine has fewer, or no, dopaminergic advantages for t ...
... defies placing narrow limits on recommended dosages. Dobutamine’s chronotropic and vasodilatory advantages recognized in adults with coronary artery disease have not always proved equally efficacious in clinical studies in children. In fact, dobutamine has fewer, or no, dopaminergic advantages for t ...
TITLE PAGE Article title: Value of sequential
... disease process, is unknown.3-5 Additionally, congestive heart failure (CHF) is often already present by the time systolic abnormalities have become manifest using echocardiography.6-11 These observations have led some workers to question the value of non-invasive monitoring of cardiac function in t ...
... disease process, is unknown.3-5 Additionally, congestive heart failure (CHF) is often already present by the time systolic abnormalities have become manifest using echocardiography.6-11 These observations have led some workers to question the value of non-invasive monitoring of cardiac function in t ...
Printable TAVR Fact Sheet - Berks Cardiologists, Ltd.
... operative risk score ≥ 8% or are judged by the heart team to be at a ≥ 15% risk of mortality for surgical aortic valve replacement. Contraindications: The bioprosthesis and delivery system are contraindicated in patients who cannot tolerate an anticoagulation/antiplatelet regimen or who have active ...
... operative risk score ≥ 8% or are judged by the heart team to be at a ≥ 15% risk of mortality for surgical aortic valve replacement. Contraindications: The bioprosthesis and delivery system are contraindicated in patients who cannot tolerate an anticoagulation/antiplatelet regimen or who have active ...
Blood Supply of the Myocardium after Temporary Coronary Occlusion
... A coronary artery and the accompanying vein were ligated temporarily for 30, 60 and 120 minutes in 39 cats. By labelling the blood with the fluorescent dye acridine orange, the intravital blood supply of the myocardium was investigated 5 minutes to 6 hours after release of the ligature. The region s ...
... A coronary artery and the accompanying vein were ligated temporarily for 30, 60 and 120 minutes in 39 cats. By labelling the blood with the fluorescent dye acridine orange, the intravital blood supply of the myocardium was investigated 5 minutes to 6 hours after release of the ligature. The region s ...
Atrial Fibrillation - CardiacAndVascular.com
... Atrial fibrillation that is caused by an underlying condition, such as hyperthyroidism, usually goes away when the underlying condition is treated. The course and treatment of atrial fibrillation that is caused by other heart disease can be more complicated. Heart disease may interfere with how eff ...
... Atrial fibrillation that is caused by an underlying condition, such as hyperthyroidism, usually goes away when the underlying condition is treated. The course and treatment of atrial fibrillation that is caused by other heart disease can be more complicated. Heart disease may interfere with how eff ...
Implantable carotid sinus baroreflex device for the treatment of drug
... 97 minutes (SD 29) (p<0.05). Of the 30 patients, 90 per cent (n=27) received the implant on the right side, with most neck incisions being longer than 5 cm. Twenty-nine patients completed the six-month follow-up and achieved the primary efficacy objective of a reduction in office-cuff systolic blood ...
... 97 minutes (SD 29) (p<0.05). Of the 30 patients, 90 per cent (n=27) received the implant on the right side, with most neck incisions being longer than 5 cm. Twenty-nine patients completed the six-month follow-up and achieved the primary efficacy objective of a reduction in office-cuff systolic blood ...